(Q39097877)

9 September 2017

title

Cetuximab inhibits oral squamous cell carcinoma invasion and metastasis via degradation of epidermal growth factor receptor (English)

1 reference

oral squamous cell carcinoma

9 September 2017

1 reference

1 reference

Wei Dai

1

1 reference

9 September 2017

Yanshu Li

2

1 reference

9 September 2017

Qing Zhou

3

1 reference

9 September 2017

Zhongfei Xu

4

1 reference

9 September 2017

Changfu Sun

5

1 reference

9 September 2017

Xuexin Tan

6

1 reference

9 September 2017

Li Lu

7

1 reference

9 September 2017

publication date

11 September 2013

1 reference

Journal of Oral Pathology & Medicine

9 September 2017

published in

1 reference

9 September 2017

volume

43

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

250-257

1 reference

Topical polyethylene glycol as a novel chemopreventive agent for oral cancer via targeting of epidermal growth factor response

9 September 2017

cites work

1 reference

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.

21 January 2018

1 reference

EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation

21 January 2018

1 reference

Epidermal growth factor receptor dependence in human tumors: more than just expression?

21 January 2018

1 reference

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification

21 January 2018

1 reference

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase

21 January 2018

1 reference

Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.

21 January 2018

1 reference

Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines

21 January 2018

1 reference

Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

21 January 2018

1 reference

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer

21 January 2018

1 reference

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

21 January 2018

1 reference

Palliative weekly chemotherapy along with cetuximab in recurrent and metastatic head and neck cancers: a retrospective analysis.

21 January 2018

1 reference

Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation

21 January 2018

1 reference

Overexpression of integrin beta 5 enhances the paracrine properties of circulating angiogenic cells via Src kinase-mediated activation of STAT3.

21 January 2018

1 reference

pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations

21 January 2018

1 reference

EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas

21 January 2018

1 reference

Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer

21 January 2018

1 reference

HGF rescues colorectal cancer cells from EGFR inhibition via MET activation

21 January 2018

1 reference

The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tong

21 January 2018

1 reference

Insulin-like growth factor receptor as a therapeutic target in head and neck cancer

21 January 2018

1 reference

Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT).

21 January 2018

1 reference

Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JOP.12116

1 reference

9 September 2017

1 reference